{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:05:37Z","timestamp":1791223537476,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2006,10,17]],"date-time":"2006-10-17T00:00:00Z","timestamp":1161043200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1007\/s10495-006-0286-3","type":"journal-article","created":{"date-parts":[[2006,10,19]],"date-time":"2006-10-19T00:03:26Z","timestamp":1161216206000},"page":"2159-2165","source":"Crossref","is-referenced-by-count":28,"title":["Spironolactone induces apoptosis and inhibits NF-\u03baB independent of the mineralocorticoid receptor"],"prefix":"10.1007","volume":"11","author":[{"given":"S\u00f8ren Ulrik Salling","family":"S\u00f8nder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Woetmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"\u00d8dum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Bendtzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,10,17]]},"reference":[{"key":"286_CR1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1006\/scbi.1997.0062","volume":"8","author":"GE Sonenshein","year":"1997","unstructured":"Sonenshein GE (1997) Rel\/NF-kappa B transcription factors and the control of apoptosis. Semin Cancer Biol 8:113\u201319","journal-title":"Semin Cancer Biol"},{"key":"286_CR2","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","volume":"18","author":"HL Pahl","year":"1999","unstructured":"Pahl HL (1999) Activators and target genes of Rel\/NF-kappaB transcription factors. Oncogene 18:6853\u2013866","journal-title":"Oncogene"},{"key":"286_CR3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/cbf.1082","volume":"22","author":"S Ali","year":"2004","unstructured":"Ali S, Mann DA (2004) Signal transduction via the NF-kappaB pathway: A targeted treatment modality for infection, inflammation and repair. Cell Biochem Funct 22:67\u20139","journal-title":"Cell Biochem Funct"},{"key":"286_CR4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrm1368","volume":"5","author":"LF Chen","year":"2004","unstructured":"Chen LF, Greene WC (2004) Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5:392\u201301","journal-title":"Nat Rev Mol Cell Biol"},{"key":"286_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1329.002","volume":"1030","author":"S Delhalle","year":"2004","unstructured":"Delhalle S, Blasius R, Dicato M, Diederich M (2004) A beginner\u2019s guide to NF-kappaB signaling pathways. Ann N Y Acad Sci 1030:1\u20133","journal-title":"Ann N Y Acad Sci"},{"key":"286_CR6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000139166","volume":"48","author":"LE Los","year":"1994","unstructured":"Los LE, Colby HD (1994) Binding of spironolactone metabolites in vivo to renal mineralocorticoid receptors in guinea pigs. Pharmacology 48:86\u20132","journal-title":"Pharmacology"},{"key":"286_CR7","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1161\/01.CIR.94.10.2566","volume":"94","author":"N Klauber","year":"1996","unstructured":"Klauber N, Browne F, Anand-Apte B, D\u2019Amato RJ (1996) New activity of spironolactone. Inhibition of angiogenesis in vitro and in vivo. Circulation 94:2566\u2013571","journal-title":"Circulation"},{"key":"286_CR8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.HYP.37.2.787","volume":"37","author":"A Fiebeler","year":"2001","unstructured":"Fiebeler A, Schmidt F, Muller DN, et\u00a0al (2001) Mineralocorticoid receptor affects AP-1 and nuclear factor-kB activation in angiotensin II-induced cardiac injury. Hypertension 37:787\u201393","journal-title":"Hypertension"},{"key":"286_CR9","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","volume":"161","author":"Y Sun","year":"2002","unstructured":"Sun Y, Zhang J, Lu L, Chen SS, Quinn MT, Weber KT (2002) Aldosterone-induced inflammation in the rat heart : Role of oxidative stress. Am J Pathol 161:1773\u2013781","journal-title":"Am J Pathol"},{"key":"286_CR10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1253\/circj.68.376","volume":"68","author":"R Matsumoto","year":"2004","unstructured":"Matsumoto R, Yoshiyama M, Omura T, et\u00a0al (2004) Effects of aldosterone receptor antagonist and angiotensin II type I receptor blocker on cardiac transcriptional factors and mRNA expression in rats with myocardial infarction. Circ J 68:376\u201382","journal-title":"Circ J"},{"key":"286_CR11","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/01.hjh.0000170379.08214.5a","volume":"23","author":"D Sanz-Rosa","year":"2005","unstructured":"Sanz-Rosa D, Cediel E, de las Heras N, et\u00a0al (2005) Participation of aldosterone in the vascular inflammatory response of spontaneously hypertensive rats: role of the NFkappaB\/IkappaB system. J Hypertens 23:1167\u2013172","journal-title":"J Hypertens"},{"key":"286_CR12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2249.2003.02249.x","volume":"134","author":"K Bendtzen","year":"2003","unstructured":"Bendtzen K, Hansen PR, Rieneck K, The Spironolactone\/Arthritis Study Group (2003) Spironolactone inhibits production of proinflammatory cytokines, including tumor necrosis factor alpha and interferon-gamma, and has potential in the treatment of arthritis. Clin Exp Immunol 134:151\u201358","journal-title":"Clin Exp Immunol"},{"key":"286_CR13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.imlet.2003.11.008","volume":"91","author":"PR Hansen","year":"2004","unstructured":"Hansen PR, Rieneck K, Bendtzen K (2004) Spironolactone inhibits production of proinflammatory cytokines by human mononuclear cells. Immunol Lett 91:87\u20131","journal-title":"Immunol Lett"},{"key":"286_CR14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-0765.2005.00792.x","volume":"40","author":"MC Grauballe","year":"2005","unstructured":"Grauballe MC, Bentzen BH, Bjornsson M, et\u00a0al (2005) The effect of spironolactone on experimental periodontitis in rats. J Periodontal Res 40:212\u201317","journal-title":"J Periodontal Res"},{"key":"286_CR15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/sj.bjp.0706700","volume":"148","author":"SU S\u00f8nder","year":"2006","unstructured":"S\u00f8nder SU, Mikkelsen M, Rieneck K, Hedegaard CJ, Bendtzen K (2006) Effects of spironolactone on human blood mononuclear cells: Mineralocorticoid receptor independent effects on gene expression and late apoptosis induction. Br J Pharmacol 148:46\u20133","journal-title":"Br J Pharmacol"},{"key":"286_CR16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10495-006-4919-3","volume":"11","author":"M Mikkelsen","year":"2006","unstructured":"Mikkelsen M, Sonder SU, Nersting J, Bendtzen K (2006) Spironolactone induces apoptosis in human mononuclear cells. Association between apoptosis and cytokine suppression. Apoptosis 11:573\u201379","journal-title":"Apoptosis"},{"key":"286_CR17","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1172\/JCI992","volume":"101","author":"C Wahl","year":"1998","unstructured":"Wahl C, Liptay S, Adler G, Schmid RM (1998) Sulfasalazine: A potent and specific inhibitor of nuclear factor kappa B. J Clin Invest 101:1163\u2013174","journal-title":"J Clin Invest"},{"key":"286_CR18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3346\/jkms.1999.14.3.231","volume":"14","author":"DM Jue","year":"1999","unstructured":"Jue DM, Jeon KI, Jeong JY (1999) Nuclear factor kappaB (NF-kappaB) pathway as a therapeutic target in rheumatoid arthritis. J Korean Med Sci 14:231\u201338","journal-title":"J Korean Med Sci"},{"key":"286_CR19","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/sj.bjp.0704870","volume":"137","author":"S Liptay","year":"2002","unstructured":"Liptay S, Fulda S, Schanbacher M, et\u00a0al (2002) Molecular mechanisms of sulfasalazine-induced T-cell apoptosis. Br J Pharmacol 137:608\u201320","journal-title":"Br J Pharmacol"},{"key":"286_CR20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.mce.2003.10.005","volume":"217","author":"SM Garthwaite","year":"2004","unstructured":"Garthwaite SM, McMahon EG (2004) The evolution of aldosterone antagonists. Mol Cell Endocrinol 217:27\u20131","journal-title":"Mol Cell Endocrinol"},{"key":"286_CR21","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1210\/en.2005-1318","volume":"147","author":"TA Williams","year":"2006","unstructured":"Williams TA, Verhovez A, Milan A, Veglio F, Mulatero P (2006) Protective effect of spironolactone on endothelial cell apoptosis. Endocrinology 147:2496\u2013505","journal-title":"Endocrinology"},{"key":"286_CR22","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/jlb.62.6.817","volume":"62","author":"T Akahoshi","year":"1997","unstructured":"Akahoshi T, Namai R, Sekiyama N, Tanaka S, Hosaka S, Kondo H (1997) Rapid induction of neutrophil apoptosis by sulfasalazine: implications of reactive oxygen species in the apoptotic process. J Leukoc Biol 62:817\u201326","journal-title":"J Leukoc Biol"},{"key":"286_CR23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10495-005-1877-0","volume":"10","author":"F Habens","year":"2005","unstructured":"Habens F, Srinivasan N, Oakley F, Mann DA, Ganesan A, Packham G (2005) Novel sulfasalazine analogues with enhanced NF-kB inhibitory and apoptosis promoting activity. Apoptosis 10:481\u201391","journal-title":"Apoptosis"},{"key":"286_CR24","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1210\/en.2004-0809","volume":"146","author":"M Lappas","year":"2005","unstructured":"Lappas M, Yee K, Permezel M, Rice GE (2005) Sulfasalazine and BAY 11-7082 interfere with the nuclear factor-kappa B and I kappa B kinase pathway to regulate the release of proinflammatory cytokines from human adipose tissue and skeletal muscle in vitro. Endocrinology 146:1491\u2013497","journal-title":"Endocrinology"},{"key":"286_CR25","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1023\/A:1012168020545","volume":"14","author":"N Takamura","year":"1997","unstructured":"Takamura N, Maruyama T, Ahmed S, Suenaga A, Otagiri M (1997) Interactions of aldosterone antagonist diuretics with human serum proteins. Pharm Res 14:522\u201326","journal-title":"Pharm Res"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-006-0286-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10495-006-0286-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-006-0286-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T18:31:10Z","timestamp":1559154670000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10495-006-0286-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,17]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["286"],"URL":"https:\/\/doi.org\/10.1007\/s10495-006-0286-3","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,17]]}}}